- Approval Id
- 0870169ed96b9249
- Drug Name
- TAFLOTAN-S OPHTHALMIC SOLUTION 0.0015%
- Product Name
- TAFLOTAN-S OPHTHALMIC SOLUTION 0.0015%
- Approval Number
- SIN14856P
- Approval Date
- 2015-09-23
- Registrant
- SANTEN PHARMACEUTICAL ASIA PTE. LTD.
- Licence Holder
- SANTEN PHARMACEUTICAL ASIA PTE. LTD.
- Drug Type
- Therapeutic
- Forensic Classification
- PRESCRIPTION ONLY MEDICINES
- Dosage Form
- SOLUTION, STERILE
- Dosage
- <p><strong>Dosage and Administration</strong><br>
Instill 1 drop in the affected eye(s) once daily.</p>
<p><strong><Precautions></strong><br>
Do not use more than once daily because more frequent administration may lessen the IOP-lowering effect.</p>
- Route Of Administration
- OPHTHALMIC
- Indication Info
- <p><strong>Indications</strong><br>
Reduction of intraocular pressure in patients with primary open-angle glaucoma or ocular hypertension.</p>
- Contraindications
- <p><strong>Contraindications (This product is contraindicated in the following patients.)</strong><br>
Patients with a history of hypersensitivity to any of the ingredients of this product. Patients with combination with products containing omidenepag isopropyl.</p>
- Atc Code
- S01EE05
- Atc Item Name
- tafluprost
- Pharma Manufacturer Name
- SANTEN PHARMACEUTICAL ASIA PTE. LTD.
- Company Detail Path
- /organization/santen-pharmaceutical-asia-pte-ltd
